Yashil disease (Buruli ulcer) - Symptoms, Causes, Treatment & Prevention

📅 Updated: May 2026 ⏱️ 6 min read ✅ Medically reviewed
```html Yashil Disease (Buruli Ulcer) – Comprehensive Medical Guide

Yashil Disease (Buruli Ulcer) – Comprehensive Medical Guide

Overview

Yashil disease is the local name used in some Central African communities for Buruli ulcer, a chronic necrotizing skin infection caused by the bacterium Mycobacterium ulcerans. The disease is characterized by painless, progressively enlarging skin lesions that can lead to severe tissue loss if left untreated.

Who it affects

  • Primarily children aged 5–15 years (≈ 50% of cases).
  • Rural residents living near slow‑moving or stagnant water bodies (rivers, swamps, wetlands).
  • Populations in West and Central Africa, with occasional cases reported in Australia, the South Pacific, and South America.

Prevalence

  • World Health Organization (WHO) estimates 2,500–3,000 new cases annually worldwide.1
  • Over 90% of cases occur in 13 endemic countries, the highest burden being in Côte d’Ivoire, Ghana, and Benin.2
  • In some hyper‑endemic villages, incidence can exceed 20 cases per 1,000 population per year.3

Symptoms

Symptoms develop slowly over weeks to months. The classic clinical progression includes four stages, but patients may present at any point.

1. Nodular stage

  • Firm, painless nodule or papule (1–3 cm) on the skin or subcutaneous tissue.
  • Often unnoticed because it does not hurt.

2. Plaque stage

  • Flat, raised lesion with a yellowish‑white or reddish hue.
  • Lesion may become >5 cm in diameter.
  • Surrounding skin may appear slightly inflamed.

3. Ulcerative stage

  • Central necrosis leads to a painless ulcer with undermined, violaceous edges.
  • Ulcer size can exceed 10 cm; depth may involve skin, fascia, or muscle.
  • Base often covered with a yellowish serous exudate; secondary bacterial infection can produce foul odor.

4. Healing stage

  • Granulation tissue forms, followed by epithelialization.
  • Scarring can be extensive, leading to contractures or functional loss, especially near joints.

Additional manifestations that may accompany the ulcer:

  • Swelling (edema) of the limb.
  • Loss of sensation in the surrounding area (rare).
  • Fever or malaise is unusual; systemic signs typically appear only with secondary infection.

Causes and Risk Factors

Primary cause

Buruli ulcer is caused by infection with Mycobacterium ulcerans. The bacterium produces a toxin called mycolactone, which destroys skin cells and suppresses the local immune response, resulting in painless necrosis.

How the bacterium reaches humans

  • Environmental exposure: The organism thrives in aquatic ecosystems; exact transmission methods are still under study.
  • Potential vectors: Insects (e.g., aquatic bugs, mosquitoes) may carry the bacteria mechanically.
  • Skin trauma: Small cuts, abrasions, or insect bites provide an entry point.

Risk factors

  • Living or working within 30 m of a slow‑moving water source.
  • Frequent exposure to wet soil or mud (e.g., farming, fishing, playing in streams).
  • Age < 15 years (due to higher outdoor activity).
  • Immunosuppression (e.g., HIV infection, diabetes, malnutrition) may increase severity.
  • Genetic susceptibility: certain HLA types have been linked to increased risk, though data are limited.

Diagnosis

Early diagnosis improves outcomes and reduces the need for extensive surgery.

Clinical evaluation

  • History of exposure to endemic areas and description of lesion progression.
  • Physical examination focusing on lesion size, depth, and location.

Laboratory & imaging tests

  1. Polymerase Chain Reaction (PCR) for IS2404 DNA – the most sensitive and specific test; detects bacterial DNA from a small tissue sample.
  2. Acid‑fast bacilli (AFB) smear – Ziehl‑Neelsen staining of ulcer tissue; less sensitive but useful where PCR is unavailable.
  3. Culture – Requires 6–12 weeks on special media; rarely performed due to time constraints.
  4. Histopathology – Skin biopsy shows necrotic tissue with a characteristic “clumped” pattern of bacilli and minimal inflammation.
  5. Ultrasonography – Helps assess depth, especially for lesions near joints; can guide surgical planning.

WHO diagnostic algorithm

In resource‑limited settings the algorithm relies on a combination of clinical presentation and a simple lab test (e.g., AFB staining). If PCR is available, it is the preferred confirmatory method.

Treatment Options

Since 2004, the WHO recommends an 8‑week antibiotic regimen combined with wound care. Surgery is now reserved for specific indications.

Antibiotic therapy

  • Rifampicin 10 mg/kg (max 600 mg) once daily + Streptomycin 15 mg/kg once daily (IM) for 8 weeks (RIF+STM)4.
  • Alternative oral regimen: Rifampicin + Clarithromycin 7.5 mg/kg twice daily (used when injections are not feasible).
  • Both regimens have >90% cure rates when started early.

Surgical interventions

  • Excisions & debridement – Indicated for extensive necrosis, functional impairment, or failure of antibiotic therapy.
  • Skin grafting – Used after adequate debridement to close large defects.
  • Physiotherapy – Essential post‑surgery to prevent contractures, especially around joints.

Wound care and adjunctive measures

  • Daily cleaning with sterile saline or dilute povidone‑iodine.
  • Application of non‑adherent dressings (e.g., hydrocolloid, alginate) to maintain a moist environment.
  • Topical antibiotics (e.g., mupirocin) only if secondary bacterial infection is suspected.
  • Analgesia for pain associated with dressing changes (paracetamol or ibuprofen).

Lifestyle & supportive care

  • Nutrition: High‑protein diet to support tissue repair.
  • Hydration: Adequate fluid intake, especially in hot climates.
  • Vaccination: Ensure routine immunizations (e.g., BCG) are up to date; BCG may provide partial protection.

Living with Yashil disease (Buruli ulcer)

Even after successful treatment, patients often need ongoing support.

Daily management tips

  1. Wound hygiene – Change dressings at least once daily or as instructed; keep the area clean and dry.
  2. Monitor for infection – Look for increased redness, warmth, swelling, pus, or foul odor.
  3. Protect the area – Use loose, breathable clothing; avoid friction or pressure on the ulcer site.
  4. Physiotherapy exercises – Perform gentle range‑of‑motion exercises recommended by a therapist to maintain joint flexibility.
  5. Nutrition – Include lean meats, beans, dairy, fruits, and vegetables; consider a protein supplement if advised.
  6. Psychosocial support – Join community support groups; depression and stigma are common, and counseling can improve adherence.

Follow‑up schedule

  • Weeks 1‑8: Weekly clinic visits for wound assessment and drug side‑effect monitoring.
  • Months 3‑6: Monthly visits; assess scar formation and functional recovery.
  • After 6 months: Annual check‑ups if extensive scarring or contracture risk remains.

Prevention

Because the exact transmission route is not fully understood, prevention focuses on reducing environmental exposure and early detection.

  • Protective clothing – Wear long sleeves, long trousers, and waterproof boots when working near stagnant water.
  • Use insect repellent – DEET‑based repellents may lower the chance of insect‑mediated transmission.
  • Avoid skin trauma – Promptly clean any cuts or abrasions with soap and water.
  • Community education – Teach children and families about early signs of Buruli ulcer.
  • Environmental measures – Where feasible, improve water flow in swamps, avoid creation of stagnant pools, and maintain clean margins around water bodies.
  • BCG vaccination – Though not fully protective, it is associated with a modest reduction in disease severity.

Complications

If treatment is delayed or inadequate, several serious complications may arise:

  • Severe tissue loss – Large ulcers can expose bone or tendons, requiring complex reconstructive surgery.
  • Functional impairment – Contractures, especially around joints (knees, elbows), can limit mobility.
  • Secondary bacterial infection – Can progress to cellulitis, osteomyelitis, or sepsis.
  • Chronic pain – Neuropathic pain may develop from nerve involvement.
  • Disfigurement & stigma – Visible scars can affect psychosocial wellbeing and economic participation.
  • Mortality – Rare, but possible in cases with extensive secondary infection or in immunocompromised patients.

When to Seek Emergency Care

Immediate medical attention is needed if you notice any of the following:
  • Rapidly spreading redness, swelling, or warmth around the ulcer (signs of cellulitis).
  • Fever ≥ 38°C (100.4°F) with chills.
  • Pus or foul odor suggesting a secondary infection.
  • Severe pain that suddenly worsens, especially if accompanied by numbness.
  • Difficulty moving a limb or joint due to pain or swelling.
  • Bleeding that does not stop after applying pressure for 10 minutes.

Call your local emergency services or go to the nearest health facility right away. Early intervention can prevent life‑threatening complications.

References:
1. World Health Organization. Buruli ulcer – Global epidemiology. 2023. WHO.
2. WHO. Buruli ulcer – Country profiles. 2022.
3. Portaels F, et al. “Buruli ulcer: emerging evidence for environmental reservoirs.” Clin Microbiol Rev. 2021;34(2).
4. WHO. Guidelines for the management of Buruli ulcer disease. 2020.
Additional information adapted from CDC, Mayo Clinic, and NIH resources.

```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References